Erkki Ruoslahti

From Wikipedia, the free encyclopedia

Erkki Ruoslahti is a cancer researcher at the Burnham Institute and University of California Santa Barbara. He has worked on a number of cancer drugs, aiming at reducing metastasis by inhibition of angiogenesis.